Fermentation by Lactobacillus enhances anti-inflammatory effect of Oyaksungisan on LPS-stimulated RAW 264.7 mouse macrophage cells

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Oh, You Chang ^a   Cho, Won Kyung ^a   Oh, Jin Hui ^a   Im, Ga Young ^a   Jeong, Yun Hee ^a   Yang, Min Cheol ^a   Ma, Jin Yeul ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AURANTIIN; CYCLOOXYGENASE 2; DEXAMETHASONE; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; HESPERIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; OYAKSUNGISAN; PROSTAGLANDIN; RUTOSIDE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TATA BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; LIPOPOLYSACCHARIDE; PLANT EXTRACT;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FERMENTATION; GENE EXPRESSION; GENE TRANSLOCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERFERON PRODUCTION; LACTOBACILLUS; MACROPHAGE; MOUSE; NONHUMAN; PROSTAGLANDIN RELEASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; INFLAMMATION; KOREAN MEDICINE; MEDICINAL PLANT; METABOLISM; PHOSPHORYLATION; PHYTOTHERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FERMENTATION; INFLAMMATION; INFLAMMATION MEDIATORS; LACTOBACILLUS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEDICINE, KOREAN TRADITIONAL; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 84857970063     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-17     Document Type: Article

References (43)

1. Ha JY, Lee SG, Yu BG. Effects of Oyaksunkisan acua-acupuncture on Adjuvant Arthritis in rats. Kor J Ori Med Pathol 2000, 14:144-154.
2. Weon JB, Ma JY, Yang HJ, Ma CJ. Neuroprotective Activity of Fermented Oyaksungisan. Kor J Pharmacogn 2011, 42:22-26.
3. Je JJ, Shin HT, Chung SH, Lee JS, Kim SS, Shin HD, Jang MH, Kim YJ, Chung JH, Kim EH, Kim CJ. Protective effects of Wuyaoshunqisan against H2O2-induced apoptosis on hippocampal cell line HiB5. Am J Chin Med 2002, 30:561-570. 10.1142/S0192415X0200048X, 12568283.
4. Kim Y, So HS, Kim JK, Park C, Lee JH, Woo WH, Cho KH, Moon BS, Park R. Anti-inflammatory effect of oyaksungisan in peripheral blood mononuclear cells from cerebral infarction patients. Biol Pharm Bull 2007, 30:1037-1041. 10.1248/bpb.30.1037, 17541150.
5. Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol 1999, 66:11-17. 10.1016/S0378-8741(98)00222-0, 10432202.
6. Cheigh HS, Park KY. Biochemical, microbiological, and nutritional aspects of kimchi (Korean fermented vegetable products). Crit Rev Food Sci Nutr 1994, 34:175-203. 10.1080/10408399409527656, 8011144.
7. Eriksson CE, Na A. Antioxidant agents in raw materials and processed foods. Biochem Soc Symp 1995, 61:221-234.
8. Minamiyama Y, Takemura S, Tsukioka T, Shinkawa H, Kobayashi F, Nishikawa Y, Kodai S, Mizuguchi S, Suehiro S, Okada S. Effect of AOB, a fermented-grain food supplement, on oxidative stress in type 2 diabetic rats. BioFactors 2007, 30:91-104. 10.1002/biof.5520300203, 18356581.
9. Deiana M, Dessi MA, Ke B, Liang YF, Higa T, Gilmour PS, Jen LS, Rahman I, Aruoma OI. The antioxidant cocktail effective microorganism × (EM-X) inhibits oxidant-induced interleukin-8 release and the peroxidation of phospholipids in vitro. Biochem Biophys Res Commun 2002, 296:1148-1151. 10.1016/S0006-291X(02)02061-2, 12207893.
10. Ronis MJ, Butura A, Korourian S, Shankar K, Simpson P, Badeaux J, Albano E, Ingelman-Sundberg M, Badger TM. Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp Biol Med (Maywood) 2008, 233:344-355.
11. Becker S, Mundandhara S, Devlin RB, Madden M. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: further mechanistic studies. Toxicol Appl Pharmacol 2005, 207:269-275. 10.1016/j.taap.2005.01.023, 15993911.
12. Pierce GF. Macrophages: important physiologic and pathologic sources of polypeptide growth factors. Am J Respir Cell Mol Biol 1990, 2:233-234.
13. Simons RK, Junger WG, Loomis WH, Hoyt DB. Acute lung injury in endotoxemic rats is associated with sustained circulating IL-6 levels and intrapulmonary CINC activity and neutrophil recruitment role of circulating TNF-α and IL-1β. Shock 1996, 6:39-45. 10.1097/00024382-199607000-00009, 8828083.
14. Guslandi M. Nitric oxide and inflammatory bowel disease. Eur J Clin Invest 1998, 28:904-907. 10.1046/j.1365-2362.1998.00377.x, 9824433.
15. Makarov SS. NF-κB as a therapeutic target in chronic inflammation recent advances. Mol Med Today 2000, 6:441-448. 10.1016/S1357-4310(00)01814-1, 11074370.
16. De Martin R, Vanhove B, Cheng Q, Hofer E, Csizmadia V, Winkler H, Bach FH. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NF-κB. EMBO J 1993, 12:2773-2779. 413527, 8334993.
17. Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004, 3:401-416. 10.1038/nrd1383, 15136788.
18. Chen C, Chen YH, Lin WW. Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophage. Immunology 1999, 97:124-129. 10.1046/j.1365-2567.1999.00747.x, 2326802, 10447723.
19. Chan ED, Riches DW. Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNF-α. Biochem Biophys Res Commun 1998, 253:790-796. 10.1006/bbrc.1998.9857, 9918806.
20. Kim YH, Lee SH, Lee JY, Choi SW, Park JW, Kwon TK. Triptolide inhibits murine inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase. Eur J Pharmacol 2004, 494:1-9. 10.1016/j.ejphar.2004.04.040, 15194445.
21. Tao JY, Zheng GH, Zhao L, Wu JG, Zhang XY, Zhang SL, Huang ZJ, Xiong FL, Li CM. Anti-inflammatory effects of ethyl acetate fraction from Melilotus suaveolens Ledeb on LPS-stimulated RAW 264.7 cells. J Ethnopharmacol 2009, 123:97-105. 10.1016/j.jep.2009.02.024, 19429346.
22. Kim HY, Kim JK, Choi JH, Jung JY, Oh WY, Kim DC, Lee HS, Kim YS, Kang SS, Lee SH, Lee SM. Hepatoprotective effect of pinoresinol on carbon tetrachloride-induced hepatic damage in mice. J Pharmacol Sci 2010, 112:105-112. 10.1254/jphs.09234FP, 20093790.
23. Choi HJ, Kang OH, Park PS, Chae HS, Oh YC, Lee YS, Choi JG, Lee GH, Kweon OH, Kwon DY. Mume Fructus water extract inhibits pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages. J Med Food 2007, 10:460-466. 10.1089/jmf.2006.198, 17887939.
24. Jo HY, Kim Y, Nam SY, Lee BJ, Kim YB, Yun YW, Ahn B. The inhibitory effect of quercitrin gallate on iNOS expression induced by lipopolysaccharide in Balb/c mice. J Vet Sci 2008, 9:267-272. 10.4142/jvs.2008.9.3.267, 2811838, 18716446.
25. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H. Differential regulation of I kappa B kinase alpha and beta by two upstream kinases, NF-kappa B-inducing kinase and mitogenactivated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 1998, 95:3537-3542. 10.1073/pnas.95.7.3537, 19871, 9520401.
26. Southan GJ, Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996, 51:383-394. 10.1016/0006-2952(95)02099-3, 8619882.
27. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003, 54:469-487.
28. Wu SJ, Ng LT. Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol Pharm Bull 2007, 30:59-62. 10.1248/bpb.30.59, 17202660.
29. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006, 25:6680-6684. 10.1038/sj.onc.1209954, 17072321.
30. Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol 2006, 6:111-130. 10.1385/CT:6:2:111, 17303919.
31. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007, 8:49-62. 10.1038/nrm2083, 17183360.
32. Gilmore TD. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene 1999, 18:6842-6844. 10.1038/sj.onc.1203237, 10602459.
33. Tian B, Brasier AR. Identification of a nuclear factor kappa B-dependent gene network. Recent Pro Hor Res 2003, 58:95-130.
34. Chen F, Kuhn DC, Sun SC, Gaydos LJ, Demers LM. Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages. Biochem Biophys Res Commun 1995, 214:839-846. 10.1006/bbrc.1995.2363, 7575553.
35. Roshak AK, Jackson JR, McGough K, Chabot-Fletcher M, Mochan E, Marshall LA. Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J Biol Chem 1996, 271:31496-31501. 10.1074/jbc.271.49.31496, 8940164.
36. Schmedtje JF, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997, 272:601-608. 10.1074/jbc.272.1.601, 8995303.
37. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994, 269:4705-4708.
38. Xie W, Merrill JR, Bradshaw WS, Simmons DL. Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch Biochem Biophys 1993, 300:247-252. 10.1006/abbi.1993.1034, 8424659.
39. Ahn KS, Noh EJ, Zhao HL, Jung SH, Kang SM, Kim YS. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-kappaB activation in RAW 264.7 cells. Life Sci 2005, 76:2315-2328. 10.1016/j.lfs.2004.10.042, 15748625.
40. Barnes PJ, Karin M. Nuclear factor-kappaB. A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071. 10.1056/NEJM199704103361506, 9091804.
41. Chen Y, Yang L, Lee TJ. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem Pharmacol 2000, 59:1445-1457. 10.1016/S0006-2952(00)00255-0, 10751555.
42. Kim YM, Lee BS, Yi KY, Paik SG. Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharideinduced RAW 264.7 macrophages. Biochem Biophys Res Commun 1997, 236:655-660. 10.1006/bbrc.1997.7031, 9245708.
43. Caivano M. Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW 264.7 macrophages. FEBS Lett 1999, 429:249-253.